Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.32 | 3e-10 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.28 | 3e-07 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.27 | 4e-07 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 2e-06 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-06 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.25 | 9e-06 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |